Efficacy and Safety of Everolimus+EC-MPS After Early CNI Elimination vs EC-MPS +Tacrolimus in Renal Transplant Recipients
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to show non-inferiority of a CNI-free regimen with
respect to the renal function at Month 9 post Tx assessed by glomerular filtration rate -
Nankivell method - as compared to the standard CNI-based regimen in de novo renal transplant
patients.